Kaletra oral solution: modification of confusing label: packaging. an infant died in France.
In France the confusing labelling of Kaletra oral solution (lopinavir/ritonavir) is thought to have played a role in a fatal overdose in a baby.
D000284:Administration, Oral; D004348:Drug Labeling; D004349:Drug Packaging; D017809:Fatal Outcome; D005602:France; D006801:Humans; D007223:Infant; D008508:Medication Errors / Q000401:mortality; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013594:Syringes
D011744:Pyrimidinones; D019438:Ritonavir